March 3, 2026

Use of the Loop Open-Source Automated Insulin Delivery System in Children with Type 1 Diabetes: Six-Month Results from a Single Center

Puntos clave

Improved glycemic outcomes without increased risk of hypoglycemia or diabetic ketoacidosis are observed.
After six months of use, the Loop system significantly enhanced diabetes management in pediatric populations.
The system's effectiveness indicates a promising alternative to traditional insulin therapies, enhancing daily life for children with type 1 diabetes.
Future studies are warranted to ensure findings are replicated across larger populations and longer timeframes.

Resumen

Use of the Loop OS-AID system resulted in improved glycemic outcomes without increased risk of hypoglycemia or DKA (Diabetic ketoacidosis). These findings support Loop as a safe and effective alternative for pediatric T1D management. Further large-scale and longer-term studies are warranted.

Preguntar a la IA

Me gusta

Guardar